Investors
Warnex is focused on providing contract laboratory services to the pharmaceutical and healthcare sectors. We are committed to quality and scientific excellence in all aspects of our business, and we have earned a reputation for providing reliable and consistent results as well as outstanding customer service. Our ultimate goal is to become a significant player in the laboratory services sector, through both acquisitions and organic growth. We have a strong track record of growth and we have acquired and successfully integrated five acquisitions in the laboratory sector.
Financial Summary
| 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|
| Revenues (‘000 $) | 21,098 | 25,499 | 25,787 | 23,647 | 22,251 |
| Employees | 291 | 288 | 256 | 259 | 250 |
| Property, plant, equip. (‘000 $) | 10,932 | 7,726 | 8,309 | 7,376 | 6,174 |
| Net earnings (‘000 $) | (18,205) | (1,597) | 2,373 | (164) | (1,559) |
| Net earnings per share ($) | (0.34) | (0.03) | 0.04 | 0.00 | (0.02) |
Latest news
- February 2, 2012
- Warnex Extends Maturity Date of Its Outstanding Debenture
- January 12, 2012
- Warnex Comments on its Listing Status
- December 20, 2011
- Warnex to Sell Its Analytical Services Division
